1Smith L,Farroni J, Baillie BR, et al. Heart transplantation an answer for end-stage heart failure. Crit Care Nurs Clin North Am, 2003,15(4):489-494.
2Aravot D, Berman M, Ben-Gal T, et al. Functional status and quality of life of heart transplant recipients surviving beyond 5 years. Transplant Proe,2000,32(4) :731-732.
3Frazier OH, Macris MP, Duncan JM, et al. Cardiac transplantation in patients over 60 years of age. Ann Thorac Surg,1998,45 (2): 129-132.
4Gao SZ, Alderman EL, Schroeder JS, et al. Progressive coronary luminal narrowing after cardiac transplantation.Circulation, 1990, 82(5 Suppl) :Ⅳ 269- Ⅳ 275.
5Billingham ME. Pathology and etiology of chronic rejection of the heart. Clin Transplant, 1994,8(3Pt2):289-292.
6Zakliczynski M, Lekston A, Swierad M,et al. Coronary artery disease in heart transplant recipients-diagnosis and treatment.Single centre experience based on results of elective coronary angiography. Kardiologia Polska, 2003, 58(2) : 109-120.
7Richter M, Skupin M, Grabs R, et al. New approach in the therapy of chronic rejection? ACE-and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model. J Heart Lung Transplant, 2000,19 ( 11 ): 1047-1055.
8Schroeder JS, Gao SZ, Alderman EL, et al. Diltiazem inhibits development of early accelerate transplant coronary disease-an interim report. Circulation, 1992,82(Suppl 3) : Ⅲ257.
9Schroeder JS, Gao SZ, Alderman EL, et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med,1993, 328(3):164-170.
10Wenke K, Meiser B, Thiery J, et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation:a four-year randomized trial. Circulation, 1997,96 (5) : 1398-1402.
